Health and Fitness Health and Fitness
Tue, February 14, 2012
[ Tue, Feb 14th 2012 ] - Market Wire
Thoratec Presentation at Leerink Swann Healthcare Conference to be Webcast
[ Tue, Feb 14th 2012 ] - Market Wire
Product Innovation Drives Record Results for Bond Laboratories
[ Tue, Feb 14th 2012 ] - Market Wire
Array BioPharma Announces Closing of Public Offer .. Common Stock and Exercise of Overallotment Option
[ Tue, Feb 14th 2012 ] - Market Wire
International Drug amp;; Explosives Detect .. orp. Launches Worldwide Retail Marketing Campaign
[ Tue, Feb 14th 2012 ] - Market Wire
International Drug & Explosives Detection Company .. orp. Launches Worldwide Retail Marketing Campaign
[ Tue, Feb 14th 2012 ] - Market Wire
Biogen Idec neemt Stromedix over
[ Tue, Feb 14th 2012 ] - Market Wire
Brookdale Senior Living Announces Acquisition and Financing Transactions
[ Tue, Feb 14th 2012 ] - Market Wire
Delcath Receives Regulatory Approval to Commercia .. ize Hepatic CHEMOSAT Delivery System in Australia
[ Tue, Feb 14th 2012 ] - Market Wire
Critical Outcome Technologies Inc. to Deliver Scientific Podium Presentation on COTI-2
[ Tue, Feb 14th 2012 ] - Market Wire
Sirona Biochem Announces Results in Key Study for Biological Inducer
[ Tue, Feb 14th 2012 ] - Market Wire
Perrigo Announces the Launch of Loratadine-D 12 S .. st Store Brand Launch That Compares to Claritin-D
[ Tue, Feb 14th 2012 ] - Market Wire
Immunovaccine to Advance Biodefense Vaccines in a NIH Funded Study
[ Tue, Feb 14th 2012 ] - Market Wire
Dynatronics Announces Second Quarter Results
[ Tue, Feb 14th 2012 ] - Market Wire
BioCorp Ventures and Senesco Enter Into License A .. or the Application of eIF5A to Sustainable Energy
[ Tue, Feb 14th 2012 ] - Market Wire
POZEN Announces February 28, 2012 Webcast of Fourth Quarter & Year End 2011 Results
[ Tue, Feb 14th 2012 ] - Market Wire
PROLOR Biotech Announces Positive Preclinical Res .. ive Study of its Long-Acting Clotting Factor VIIa
[ Tue, Feb 14th 2012 ] - Market Wire
Trimel Pharmaceuticals' Female Sexual Dysfunction Program Achieves Key Milestones
[ Tue, Feb 14th 2012 ] - Market Wire
Warnex Suspends Sale of Analytical Services Division
[ Tue, Feb 14th 2012 ] - Market Wire
Synageva BioPharma to Present at the Leerink Swann 2012 Global Healthcare Conference
[ Tue, Feb 14th 2012 ] - Market Wire
Amedisys Issues Heart Health Month Call-to-Action
[ Tue, Feb 14th 2012 ] - Market Wire
Marina Biotech Announces Closure of Cambridge Sit .. tion of R&;;D Operations in Bothell, WA
[ Tue, Feb 14th 2012 ] - Market Wire
AVEO Reports 2011 Financial Results and Highlights Fourth Quarter Progress
[ Tue, Feb 14th 2012 ] - Market Wire
STAAR Surgical Previews Strong Visian ICLa" Presence at the Upcoming World Ophthalmology Congress
[ Tue, Feb 14th 2012 ] - Market Wire
HeartWare Announces Date for FDA Advisory Committee Panel
[ Tue, Feb 14th 2012 ] - Market Wire
Santarus Increases Revolving Line of Credit to $35 Million and Extends Maturity to February 2015
Mon, February 13, 2012
[ Mon, Feb 13th 2012 ] - Market Wire
Pharming and Transmedic announce distribution agreement for RUCONEST
[ Mon, Feb 13th 2012 ] - Market Wire
U.S. FDA Grants Priority Review for Truvada for Reducing the Risk of Acquiring HIV Infection
[ Mon, Feb 13th 2012 ] - Market Wire
Molina Healthcare of Ohio Receives "Commendable" NCQA Status
[ Mon, Feb 13th 2012 ] - Market Wire
Law Offices of Howard G. Smith Announces Investigation of SeraCare Life Sciences, Inc.
[ Mon, Feb 13th 2012 ] - Market Wire
Baxter to Host Investor Conference on October 9, 2012

Baxter to Host Investor Conference on October 9, 2012


Published on 2012-02-13 14:21:42 - Market Wire
  Print publication without navigation


DEERFIELD, Ill.--([ ])--Baxter International Inc. (NYSE: BAX) announced today that it will host its 2012 Investor Conference on Tuesday, October 9, 2012 at the Ritz-Carlton Hotel in Chicago, IL.

Please visit the investor section of Baxteras website at [ www.baxter.com ] to obtain additional details, including a link to register for the event.

Baxter International Inc. develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide.

Contributing Sources